Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 6.26% | 221.27 | 0.0% | $1938.34m | |
| BIIB | Biogen, Inc. | -2.47% | 371.50 | 1.7% | $1302.01m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -8.81% | 11.69 | 0.7% | $817.17m | |
| NVAX | Novavax, Inc. | 7.56% | 194.68 | 79.8% | $807.42m | |
| AMGN | Amgen, Inc. | -0.35% | 239.41 | 1.3% | $661.17m | |
| BNTX | BioNTech SE | 4.25% | 235.70 | 0.0% | $576.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.34% | 188.34 | 1.9% | $535.92m | |
| GILD | Gilead Sciences, Inc. | -0.68% | 66.90 | 1.0% | $494.68m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.31% | 532.60 | 2.7% | $387.20m | |
| ILMN | Illumina, Inc. | 0.55% | 463.57 | 3.5% | $351.28m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.71% | 179.38 | 2.0% | $337.51m | |
| OCGN | Ocugen, Inc. | -4.20% | 7.09 | 0.0% | $328.32m | |
| TXG | 10X Genomics, Inc. | 0.02% | 197.91 | 0.0% | $177.37m | |
| EXAS | EXACT Sciences Corp. | 0.37% | 128.13 | 18.1% | $177.05m | |
| TECH | Bio-Techne Corp. | 0.15% | 440.86 | 4.5% | $164.08m |
Company Profile
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.